From the Revisto team to you, we're wishing you the happiest of holidays and a wonderful start to 2025.
Revisto
Software Development
Austin, TX 411 followers
Accelerating time to market for life sciences marketing materials, while ensuring quality and compliance.
About us
We're enabling the next generation of data-driven, personalized, and engaging life sciences marketing through streamlined, AI-powered MLR review technology. Our mission is to optimize the release cycle, reduce cost, and eliminate compliance risk of releasing promotional materials in the pharmaceutical industry, while improving quality and consistency. We achieve this by applying deep industry knowledge in cutting-edge technology to automate the compliance requirements and best practices for our customers. We strive not only to uphold the highest standards of accuracy and compliance, but also to enable the generation of data-driven, personalized, and engaging content that results in positive patient outcomes. At the heart of our offerings is our AI-driven platform that learns from regulations, industry best practices, and our customers’ historical actions. Recommendations provided by our platform significantly reduce promotional material release time, and this level of efficiency has already earned us the trust of a Top 5 pharmaceutical company. At Revisto, we believe in transparency and understand that trust is earned through consistent performance and open communication. We are committed to delivering results for our customers and fostering relationships built on mutual respect and shared success. Join us as we continue to innovate and shape the future of pharmaceutical marketing.
- Website
-
www.revisto.com
External link for Revisto
- Industry
- Software Development
- Company size
- 11-50 employees
- Headquarters
- Austin, TX
- Type
- Privately Held
- Specialties
- AI, Marketing, Life Sciences, Biopharma, Compliance, MLR Reviews , Startup, Content Creation, and Quality
Locations
-
Primary
Get directions
Austin, TX, US
Employees at Revisto
Updates
-
See how Revisto is helping life sciences companies move through their MLR review process more quickly, with the confidence that comes with knowing every promotional communication is properly supported by claims. Learn more at www.revisto.com
-
-
Revisto is streamlining MLR review for marketing materials, helping life sciences companies get their game-changing treatments to market faster—without sacrificing quality and compliance. Ready to learn more? Reach out for a free demo: https://lnkd.in/gbd7kTUK
-
-
With almost half of #pharma industry professionals saying that a lack of specific skills and talent is hindering their #digitaltransformation, partnering with professionals who have expertise in applying technology to pharma is a no-brainer. Revisto's AI-powered MLR review solution is a game changer for life sciences companies who want to accelerate speed to market for marketing materials, while reducing the burden on their teams. Even better? It also helps tackle the regulation and compliance challenges 39% of those surveyed mentioned, too. https://lnkd.in/gnNPMuTc
-
Congratulations to Eli Lilly and Company today's announcement of Zepbound delivering 47% greater weight loss compared to Wegovy, while having the same method and frequency of administration.
News for people living with obesity: Today we shared topline results from a head-to-head clinical trial comparing two treatments for adults living with obesity or overweight. Learn more: https://e.lilly/3CUQBG2
-
We're thrilled to see Revisto featured in Fortune, MM+M, The Information, and BioSpace after announcing our $4M seed funding last week! This funding will allow us to make huge strides toward our goal of rewriting the future of pharmaceutical marketing compliance. Missed the big news? Read the press release: https://lnkd.in/gJK7jqqr
-
-
Exciting news! Revisto secures $4 million in new funding to revolutionize the costly, time-consuming, and often frustrating MLR process for pharma and life science companies. Our AI-driven solution is now poised to: • Accelerate time-to-market for life-changing products • Drive efficiency in #pharma marketing operations • Significantly reduce costs by up $15M for each product We're excited to receive the support of LiveOak Ventures, Eli Lilly and Company, Tau Ventures, and Arkin Digital Health in our journey. We're just getting started! Follow along here as we rewrite the future of pharmaceutical marketing compliance. See the latest in Yahoo Finance in comments. #AIinPharma #MarketingCompliance #StartupFunding #HealthTech
-
-
Our platform is helping life sciences save time and money on their MLR reviews–without sacrificing quality or compliance. Get a free demo at revisto.com. #AI #lifesciences #biopharma #MLR #marketing
-
-
Across life sciences companies, there’s one universal truth: MLR reviews are crucial–but time consuming, complex, and expensive. Revisto uses the power of AI to help companies accelerate time to market for their most important marketing materials, giving them a competitive edge and helping them save over $15M annually per brand. Get to know us at revisto.com #AI #lifesciences #biopharma #MLR #marketing
-
-
FDA has released a draft guidance for industry on "Addressing Misinformation About Medical Devices and Prescription Drugs." This guidance outlines how firms can voluntarily provide tailored responses to internet-based misinformation about their approved/cleared drugs. Pharma companies have the option to address specific instances of misinformation created by independent third parties, such as influencers, HCPs, or nurses. However, the responses should be directly relevant to the identified misinformation. Questions for discussion: 1. Do you think there's enough clarity on what "directly related" means? 2. Given the rapid spread of information on social media, do you foresee challenges for the industry in providing timely responses while adhering to these guidelines?